<!doctype html>
<html>
<head>
  <meta charset="utf-8" />
  
  
  <title>egeulgen_CV.knit</title>

  
  
    <link href="data:text/css,%0Ahtml%2C%20body%2C%20div%2C%20span%2C%20applet%2C%20object%2C%20iframe%2C%0Ah1%2C%20h2%2C%20h3%2C%20h4%2C%20h5%2C%20h6%2C%20p%2C%20blockquote%2C%20pre%2C%0Aa%2C%20abbr%2C%20acronym%2C%20address%2C%20big%2C%20cite%2C%20code%2C%0Adel%2C%20dfn%2C%20em%2C%20img%2C%20ins%2C%20kbd%2C%20q%2C%20s%2C%20samp%2C%0Asmall%2C%20strike%2C%20strong%2C%20sub%2C%20sup%2C%20tt%2C%20var%2C%0Ab%2C%20u%2C%20i%2C%20center%2C%0Adl%2C%20dt%2C%20dd%2C%20ol%2C%20ul%2C%20li%2C%0Afieldset%2C%20form%2C%20label%2C%20legend%2C%0Atable%2C%20caption%2C%20tbody%2C%20tfoot%2C%20thead%2C%20tr%2C%20th%2C%20td%2C%0Aarticle%2C%20aside%2C%20canvas%2C%20details%2C%20embed%2C%0Afigure%2C%20figcaption%2C%20footer%2C%20header%2C%20hgroup%2C%0Amenu%2C%20nav%2C%20output%2C%20ruby%2C%20section%2C%20summary%2C%0Atime%2C%20mark%2C%20audio%2C%20video%20%7B%0Amargin%3A%200%3B%0Apadding%3A%200%3B%0Aborder%3A%200%3B%0Afont%2Dsize%3A%20100%25%3B%0Afont%3A%20inherit%3B%0Avertical%2Dalign%3A%20baseline%3B%0A%7D%0A%0Aarticle%2C%20aside%2C%20details%2C%20figcaption%2C%20figure%2C%0Afooter%2C%20header%2C%20hgroup%2C%20menu%2C%20nav%2C%20section%20%7B%0Adisplay%3A%20block%3B%0A%7D%0Abody%20%7B%0Aline%2Dheight%3A%201%3B%0Abackground%2Dcolor%3A%20white%3B%0A%7D%0Aol%2C%20ul%20%7B%0Alist%2Dstyle%3A%20none%3B%0A%7D%0Ablockquote%2C%20q%20%7B%0Aquotes%3A%20none%3B%0A%7D%0Ablockquote%3Abefore%2C%20blockquote%3Aafter%2C%0Aq%3Abefore%2C%20q%3Aafter%20%7B%0Acontent%3A%20%27%27%3B%0Acontent%3A%20none%3B%0A%7D%0Atable%20%7B%0Aborder%2Dcollapse%3A%20collapse%3B%0Aborder%2Dspacing%3A%200%3B%0A%7D%0A%0Abody%20%7B%0Afont%3A%20normal%20normal%20400%3B%0Afont%2Dsize%3A%20100%25%3B%0Aline%2Dheight%3A%201%2E5em%3B%0A%0Afont%2Dfamily%3A%20Avenir%2CVerdana%2Csans%2Dserif%3B%0Amargin%2Dtop%3A%201em%3B%0Amargin%2Dleft%3A%201em%3B%0A%7D%0Ap%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dbottom%3A%200%2E7em%3B%0Amargin%2Dright%3A%200%3B%0Awidth%3A%2055%25%3B%0A%7D%0A%2Ecsl%2Dleft%2Dmargin%20%7B%0Aposition%3A%20relative%3B%0Afloat%3A%20left%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dleft%3A%20%2D3em%3B%0Amargin%2Dbottom%3A%200%2E7em%3B%0Amargin%2Dright%3A%200%2E5em%3B%0A%7D%0A%2Ecsl%2Dright%2Dinline%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dbottom%3A%200%2E7em%3B%0Amargin%2Dright%3A%200%3B%0Awidth%3A%2055%25%3B%0A%7D%0Acode%20%7B%0Afont%3A%20normal%20normal%3B%0Afont%2Dsize%3A%2090%25%3B%0A%0Afont%2Dfamily%3A%20Monaco%2CMenlo%2Cmonospace%2Csans%2Dserif%3B%0Acolor%3A%20%23aaa%3B%0A%7D%0Ap%20code%20%7B%0Aposition%3A%20absolute%3B%0Atext%2Dalign%3A%20right%3B%0Aright%3A%20%2D20%25%3B%0A%7D%0Aul%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Awidth%3A%2075%25%3B%0Amargin%2Dbottom%3A%201%2E5em%3B%0Amargin%2Dtop%3A%20%2D0%2E5em%3B%0A%7D%0A%0A%0Ali%20%7B%0A%0Apadding%2Dleft%3A%201%2E25em%3B%0Atext%2Dindent%3A%20%2D1%2E25em%3B%0A%0A%7D%0Ali%20ul%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%200%3B%0Awidth%3A%20100%25%3B%0Amargin%2Dtop%3A%200%2E25em%3B%0A%7D%0Ah1%2Ch2%2Ch3%2Ch4%20%7B%0Afont%2Dweight%3A%20400%3B%0Afont%2Dfamily%3A%20Avenir%2CCousine%2CVerdana%2Csans%2Dserif%3B%0Awidth%3A%2080%25%3B%0A%7D%0Ah1%20%7B%0Atext%2Dalign%3A%20left%3B%0Afont%2Dsize%3A%203em%3B%0Aline%2Dheight%3A%201em%3B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0A%7D%0Ah1%2Bp%20%7B%0A%0Afont%2Dstyle%3A%20italic%3B%0Afont%2Dsize%3A%20110%25%3B%0A%7D%0Ah2%20%7B%0Afont%2Dsize%3A%201%2E1em%3B%0Acolor%3A%20%23bc412b%3B%0Amargin%2Dtop%3A%203em%3B%0Aposition%3A%20relative%3B%0Atop%3A%201%2E4em%3B%0Atext%2Dalign%3A%20right%3B%0Awidth%3A%2020%25%3B%0A%7D%0Ah3%20%7B%0Afont%2Dsize%3A%201em%3B%0Aline%2Dheight%3A%202em%3B%0Aposition%3A%20relative%3B%0Atop%3A%201%2E7em%3B%0Atext%2Dalign%3A%20right%3B%0Awidth%3A%2020%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20inherit%3B%0A%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%2339f%0A%7D%0A%23webaddress%20%7B%0Amargin%2Dtop%3A%201em%3B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Acolor%3A%20%23bc412b%3B%0Afont%2Dfamily%3A%20Monaco%2CMenlo%2Cmonospace%2Csans%2Dserif%3B%0Afont%2Dsize%3A%20100%25%3B%0A%7D%0A%23webaddress%20a%20%7B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aem%20%7B%0A%0Afont%2Dstyle%3A%20italic%3B%0A%7D%0Astrong%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0A%23address%20%7B%0Adisplay%3A%20none%3B%0A%7D%0A%0A" type="text/css" rel="stylesheet" media="screen">
  <link href="data:text/css,%0Ahtml%2C%20body%2C%20div%2C%20span%2C%20applet%2C%20object%2C%20iframe%2C%0Ah1%2C%20h2%2C%20h3%2C%20h4%2C%20h5%2C%20h6%2C%20p%2C%20blockquote%2C%20pre%2C%0Aa%2C%20abbr%2C%20acronym%2C%20address%2C%20big%2C%20cite%2C%20code%2C%0Adel%2C%20dfn%2C%20em%2C%20img%2C%20ins%2C%20kbd%2C%20q%2C%20s%2C%20samp%2C%0Asmall%2C%20strike%2C%20strong%2C%20sub%2C%20sup%2C%20tt%2C%20var%2C%0Ab%2C%20u%2C%20i%2C%20center%2C%0Adl%2C%20dt%2C%20dd%2C%20ol%2C%20ul%2C%20li%2C%0Afieldset%2C%20form%2C%20label%2C%20legend%2C%0Atable%2C%20caption%2C%20tbody%2C%20tfoot%2C%20thead%2C%20tr%2C%20th%2C%20td%2C%0Aarticle%2C%20aside%2C%20canvas%2C%20details%2C%20embed%2C%0Afigure%2C%20figcaption%2C%20footer%2C%20header%2C%20hgroup%2C%0Amenu%2C%20nav%2C%20output%2C%20ruby%2C%20section%2C%20summary%2C%0Atime%2C%20mark%2C%20audio%2C%20video%20%7B%0Amargin%3A%200%3B%0Apadding%3A%200%3B%0Aborder%3A%200%3B%0Afont%2Dsize%3A%20100%25%3B%0Afont%3A%20inherit%3B%0Avertical%2Dalign%3A%20baseline%3B%0A%7D%0A%0Aarticle%2C%20aside%2C%20details%2C%20figcaption%2C%20figure%2C%0Afooter%2C%20header%2C%20hgroup%2C%20menu%2C%20nav%2C%20section%20%7B%0Adisplay%3A%20block%3B%0A%7D%0Abody%20%7B%0Aline%2Dheight%3A%201%3B%0A%7D%0Aol%2C%20ul%20%7B%0Alist%2Dstyle%3A%20none%3B%0A%7D%0Ablockquote%2C%20q%20%7B%0Aquotes%3A%20none%3B%0A%7D%0Ablockquote%3Abefore%2C%20blockquote%3Aafter%2C%0Aq%3Abefore%2C%20q%3Aafter%20%7B%0Acontent%3A%20%27%27%3B%0Acontent%3A%20none%3B%0A%7D%0Atable%20%7B%0Aborder%2Dcollapse%3A%20collapse%3B%0Aborder%2Dspacing%3A%200%3B%0A%7D%0A%0Abody%20%7B%0Afont%3A%20normal%20normal%20400%3B%0Afont%2Dsize%3A%2012pt%3B%0Aline%2Dheight%3A%201%2E35em%3B%0A%0Afont%2Dfamily%3A%20Avenir%2CVerdana%2Csans%2Dserif%3B%0A%0A%7D%0Ap%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dbottom%3A%200%2E2em%3B%0Amargin%2Dright%3A%200%3B%0Awidth%3A%2060%25%3B%0A%7D%0A%2Ecsl%2Dleft%2Dmargin%20%7B%0Aposition%3A%20relative%3B%0Afloat%3A%20left%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dleft%3A%20%2D3em%3B%0Amargin%2Dbottom%3A%200%2E2em%3B%0Amargin%2Dright%3A%200%2E5em%3B%0A%7D%0A%2Ecsl%2Dright%2Dinline%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Amargin%2Dbottom%3A%200%2E2em%3B%0Amargin%2Dright%3A%200%3B%0Awidth%3A%2070%25%3B%0A%7D%0Acode%20%7B%0Afont%3A%20normal%20normal%3B%0Afont%2Dsize%3A%2090%25%3B%0A%0Afont%2Dfamily%3A%20Monaco%2CMenlo%2Cmonospace%2Csans%2Dserif%3B%0Acolor%3A%20%23ccc%3B%0A%7D%0Ap%20code%20%7B%0Aposition%3A%20absolute%3B%0Atext%2Dalign%3A%20right%3B%0Aright%3A%20%2D20%25%3B%0A%7D%0Aul%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Awidth%3A%2075%25%3B%0Amargin%2Dbottom%3A%201em%3B%0A%0A%7D%0A%0A%0Ali%20%7B%0A%0Apadding%2Dleft%3A%201%2E25em%3B%0Atext%2Dindent%3A%20%2D1%2E25em%3B%0A%0A%7D%0Ali%20ul%20%7B%0Aposition%3A%20relative%3B%0Aleft%3A%200%3B%0Awidth%3A%20100%25%3B%0Amargin%2Dtop%3A%200%2E25em%3B%0A%7D%0Ah1%2Ch2%2Ch3%2Ch4%20%7B%0Afont%2Dweight%3A%20400%3B%0Afont%2Dfamily%3A%20Avenir%2CCousine%2CVerdana%2Csans%2Dserif%3B%0Awidth%3A%2080%25%3B%0A%7D%0Ah1%20%7B%0Atext%2Dalign%3A%20left%3B%0Afont%2Dsize%3A%203em%3B%0Aline%2Dheight%3A%201em%3B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0A%7D%0Ah1%2Bp%20%7B%0A%0Afont%2Dstyle%3A%20italic%3B%0Afont%2Dsize%3A%20110%25%3B%0A%7D%0Ah2%20%7B%0Afont%2Dsize%3A%201%2E1em%3B%0Acolor%3A%20%23a00%3B%0Amargin%2Dtop%3A%202em%3B%0Aposition%3A%20relative%3B%0Atop%3A%201%2E2em%3B%0Atext%2Dalign%3A%20right%3B%0Awidth%3A%2020%25%3B%0A%7D%0Ah3%20%7B%0Afont%2Dsize%3A%201em%3B%0Aline%2Dheight%3A%202em%3B%0Acolor%3A%20%23ccc%3B%0Aposition%3A%20relative%3B%0Atop%3A%201%2E6em%3B%0Atext%2Dalign%3A%20right%3B%0Awidth%3A%2020%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20inherit%3B%0Atext%2Ddecoration%3Anone%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%2339f%0A%7D%0A%23webaddress%20%7B%0Amargin%2Dtop%3A%201em%3B%0Aposition%3A%20relative%3B%0Aleft%3A%2025%25%3B%0Acolor%3A%20%23ccc%3B%0Afont%2Dfamily%3A%20Monaco%2CMenlo%2Cmonospace%2Csans%2Dserif%3B%0Afont%2Dsize%3A%2090%25%3B%0A%7D%0A%23webaddress%20a%20%7B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aem%20%7B%0Afont%2Dstyle%3A%20normal%3B%0Acolor%3A%20%232d4e5e%0A%7D%0Astrong%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0A%23ghbutton%20%7B%0Adisplay%3A%20none%3B%0Avisibility%3A%20hidden%3B%0A%7D%0A" type="text/css" rel="stylesheet" media="print">
</head>
<body>
    <div id="main">
    <div id="content">
      <h1>Ege Ulgen</h1>
      <p>MD, PhD</p>
      <p>Genomics England Limited</p>

      <div id="webaddress">
      |
      <i class="fa fa-comment"></i> he/him |
      <i class="fa fa-phone"></i> +44 7796 427839 |
      
      <i class="fa fa-envelope"></i> <a href="mailto:Ege.Ulgen@genomicsengland.co.uk" class="email">Ege.Ulgen@genomicsengland.co.uk</a> |
      
      <i class="fa fa-github"></i> <a href="https://github.com/egeulgen">egeulgen</a> |
      <i class="fa fa-linkedin"></i> <a href="https://www.linkedin.com/in/ege-ulgen/">ege-ulgen</a> |
      
      
      
      </div>

      <div id="education" class="section level1">
      <h1>Education</h1>
      <p>
      <code>2016-2022</code> <strong>Ph.D., Biostatistics and
      Bioinformatics</strong> (Acibadem University)
      </p>
      <p>
      <code>2009-2015</code> <strong>M.D., summa cum laude</strong>
      (Acibadem University)
      </p>
      </div>
      <div id="experience" class="section level1">
      <h1>Experience</h1>
      <p>
      <code>2023-</code> <strong>Genomics England</strong>
      Bioinformatics Engineer (Developing features for and maintaining
      software for the cancer genomic medicine service.)
      </p>
      <p>
      <code>2018-2022</code> <strong>Epigenetiks</strong> Bioinformatics
      Specialist (Worked on developing and maintaining multiple -omics
      analysis pipelines for the local medical diagnostics company.
      Responsibilities included: implementation, continuous development
      and maintenance of whole exome sequencing analysis pipeline for
      aiding the diagnosis of undiagnosed subjects with rare diseases,
      and whole exome sequencing analysis pipeline for cancer
      diagnostics and prognostics.)
      </p>
      <p>
      <code>2018</code> <strong>Akalin Lab, Max-Delbrück-Centrum für
      Molekulare Medizin</strong> Visiting Researcher (Worked on a
      project on the effects of doublet cells on single-cell RNAseq
      analysis. Using a real data set and simulations, I demonstrated
      that doublets cause pseudo-paths (false patterns of
      differentiation), negatively affect discrimination between
      different cell types and have a negative effect on imputation
      results.)
      </p>
      <p>
      <code>2015-2022</code> <strong>NeuroOncology Technologies</strong>
      Bioinformatics Consultant (Developed and maintained the Whole
      Exome Sequencing pipeline for the local medical diagnostics
      company based in Istanbul-Turkey. The pipeline allows for the
      identification of clinically–relevant genomics findings in brain
      tumors, especially regarding gliomas)
      </p>
      <p>
      <code>2011-2014</code> <strong>Yale University School of
      Medicine</strong> Research Internships (Research in neurogenetics,
      particularly malformations of cortical development, utilizing
      molecular techniques to investigate the underlying
      genetic/molecular mechanisms, analyzing Whole Exome Sequencing
      results and verifying relevant findings. Research in brain
      tumours, performing functional in-vitro analyses to investigate
      the effect of a SNP in the pathogenesis of gliomas.)
      </p>
      <p>
      <code>2012-</code> <strong>ACU Brain Tumor Research Group</strong>
      Research Group Member (Participate in research on brain tumors,
      particularly on gliomas. I assist in biostatistical as well as
      bioinformatics analyses, focusing on the integration of molecular
      biological and clinical data to improve diagnosis, prognosis and
      treatment of glioma.)
      </p>
      </div>
      <div id="skills" class="section level1">
      <h1>Skills</h1>
      <div id="programming" class="section level2">
      <h2>Programming</h2>
      <p>python, R, bash, C++</p>
      </div>
      <div id="development" class="section level2">
      <h2>Development</h2>
      <p>git, Docker, GitLab CI, GitHub Actions, PyCharm</p>
      </div>
      </div>
      <div id="strengths" class="section level1">
      <h1>Strengths</h1>
      <p><strong>Curiosity</strong> Proactively seeks innovative
      solutions.</p>
      <p><strong>Time Management</strong> Effectively prioritizes tasks,
      ensuring timely completion of milestones.</p>
      <p><strong>Quick Learner</strong> Adapts to new challenges
      swiftly.</p>
      </div>
      <div id="software" class="section level1">
      <h1>Software</h1>
      <p>
      <code>2.3.0</code> pathfindR (Enrichment Analysis Utilizing Active
      Subnetworks)
      </p>
      <p>
      <code>1.0.1</code> PANACEA (Personalized Network-Based Anti-Cancer
      Therapy Evaluation)
      </p>
      <p>
      <code>0.4.1</code> driveR (Prioritizing Cancer Driver Genes Using
      Genomics Data)
      </p>
      <p>
      <code>2.0.0</code> pathfindR.data (Data Package for `pathfindR’)
      </p>
      </div>
      <div id="certification" class="section level1">
      <h1>Certification</h1>
      <p>
      <code>2016</code> Certificate in Machine Learning (Grade: 94.8% –
      coursera.org/verify/7QETTCDWHXHP)
      </p>
      <p>
      <code>2018</code> Certificate in Finding Hidden Messages in DNA
      (Bioinformatics I) (with Honors) (Grade: 96.0% –
      coursera.org/verify/B5Y2QZ4AWTCL)
      </p>
      <p>
      <code>2019</code> Certificate in Genome Sequencing (Bioinformatics
      II) (with Honors) (Grade: 99.0% –
      coursera.org/verify/242DMGMNGFXA)
      </p>
      <p>
      <code>2019</code> Certificate in Comparing Genes, Proteins, and
      Genomes (Bioinformatics III) (with Honors) (Grade: 100% –
      coursera.org/verify/N3B77QC9N7V6)
      </p>
      <p>
      <code>2019</code> Certificate in Molecular Evolution
      (Bioinformatics IV) (with Honors) (Grade: 100% –
      coursera.org/verify/TM3MWQPRPS47)
      </p>
      <p>
      <code>2019</code> Certificate in Genomic Data Science and
      Clustering (Bioinformatics V) (with Honors) (Grade: 94.0% –
      coursera.org/verify/AGX8F2V8PU3G)
      </p>
      <p>
      <code>2019</code> Certificate in Bioinformatics Capstone: Big Data
      in Biology (Grade: 100% – coursera.org/verify/9AKDLPVN9M2U)
      </p>
      <p>
      <code>2019</code> Certificate in Bioinformatics Specialization
      (coursera.org/verify/35KWGTCVTJX8)
      </p>
      </div>
      <div id="publications" class="section level1">
      <h1>Publications</h1>
      <div id="bibliography">
      <div id="ref-23" class="csl-entry">
      <div class="csl-left-margin">1. </div><div class="csl-right-inline">Kaya, D., Ülgen, E., Kocagöz, A., &amp;
      Sezerman, O. (2023). A comparison of various feature extraction
      and machine learning methods for antimicrobial resistance
      prediction in streptococcus pneumoniae. <em>Frontiers in
      Antibiotics</em>.</div>
      </div>
      <div id="ref-24" class="csl-entry">
      <div class="csl-left-margin">2. </div><div class="csl-right-inline">Ulgen, E., Ozisik, O., &amp; Sezerman, O.
      (2023). PANACEA: Network-based methods for pharmacotherapy
      prioritization in personalized oncology.
      <em>Bioinformatics</em>.</div>
      </div>
      <div id="ref-26" class="csl-entry">
      <div class="csl-left-margin">3. </div><div class="csl-right-inline">Levi, C., Uçal, Y., Planchon, S., Ülgen,
      E., Kumru, P., Ulutaş, P., Sezerman, U., &amp; …. (2023). Proteome
      analysis of human and goat colostrum: A closer look at whey
      fractions. <em>Acibadem Saglik Bilimleri Dergisi</em>.</div>
      </div>
      <div id="ref-27" class="csl-entry">
      <div class="csl-left-margin">4. </div><div class="csl-right-inline">Cansu, A., Yasemin, U., Planchon, S.,
      Ülgen, E., KUMRU, P., ULUTAŞ, P., &amp; …. (2023). Proteome
      analysis of human and goat colostrum: A closer look at whey
      fractions. <em>Acıbadem Üniversitesi Sağlık Bilimleri
      Dergisi</em>.</div>
      </div>
      <div id="ref-19" class="csl-entry">
      <div class="csl-left-margin">5. </div><div class="csl-right-inline">Dogan, B., Gumusoglu, E., Ulgen, E.,
      Sezerman, O., &amp; Gunel, T. (2022). Integrated bioinformatics
      analysis of validated and circulating miRNAs in ovarian cancer.
      <em>Genomics &amp; Informatics</em>.</div>
      </div>
      <div id="ref-21" class="csl-entry">
      <div class="csl-left-margin">6. </div><div class="csl-right-inline">Keleş, I., Günel, T., Özgör, B., Ülgen,
      E., Gümüşoğlu, E., Hosseini, M., &amp; …. (2022). Gene pathway
      analysis of the endometrium at the start of the window of
      implantation in women with unexplained infertility and unexplained
      recurrent pregnancy loss: Is …. <em>Human Fertility</em>.</div>
      </div>
      <div id="ref-3" class="csl-entry">
      <div class="csl-left-margin">7. </div><div class="csl-right-inline">Yousef, M., Ülgen, E., &amp; Sezerman, O.
      (2021). CogNet: Classification of gene expression data based on
      ranked active-subnetwork-oriented KEGG pathway enrichment
      analysis. <em>PeerJ Computer Science</em>.</div>
      </div>
      <div id="ref-10" class="csl-entry">
      <div class="csl-left-margin">8. </div><div class="csl-right-inline">Ülgen, E., &amp; Sezerman, O. (2021).
      driveR: A novel method for prioritizing cancer driver genes using
      somatic genomics data. <em>BMC Bioinformatics</em>.</div>
      </div>
      <div id="ref-12" class="csl-entry">
      <div class="csl-left-margin">9. </div><div class="csl-right-inline">Albayrak, İ., Azhari, F., Çolak, E.,
      Balcı, B., Ülgen, E., Sezerman, U., Baştu, E., &amp; …. (2021).
      Endometrial gene expression profiling of recurrent implantation
      failure after in vitro fertilization. <em>Molecular Biology
      Reports</em>.</div>
      </div>
      <div id="ref-20" class="csl-entry">
      <div class="csl-left-margin">10. </div><div class="csl-right-inline">Ülgen, E., Aras, F., Coşgun, E.,
      Erşen-Danyeli, A., Dinçer, A., Usseli, M., &amp; …. (2021).
      Correlation of anatomical involvement patterns of insular gliomas
      with subnetworks of the limbic system. <em>Journal of
      Neurosurgery</em>.</div>
      </div>
      <div id="ref-25" class="csl-entry">
      <div class="csl-left-margin">11. </div><div class="csl-right-inline">Ülgen, E., Can, Ö., Bilguvar, K., Boylu,
      C. A., Yüksel, Ş. K., &amp; …. (2021). Sequential filtering for
      clinically relevant variants as a method for clinical
      interpretation of whole exome sequencing findings in glioma.
      <em>BMC Medical Genomics</em>.</div>
      </div>
      <div id="ref-28" class="csl-entry">
      <div class="csl-left-margin">12. </div><div class="csl-right-inline">Everest, E., Ülgen, E., Uygunoglu, U.,
      Tutuncu, M., Saip, S., Sezerman, O., &amp; …. (2021).
      Investigation of multiple sclerosis-related pathways through the
      integration of genomic and proteomic data. <em>PeerJ</em>.</div>
      </div>
      <div id="ref-14" class="csl-entry">
      <div class="csl-left-margin">13. </div><div class="csl-right-inline">Keleş, I., Ülgen, E., Erkan, M., Çelik,
      S., Aydın, Y., Önem, A., Kandemir, H., &amp; …. (2020). Comparison
      of endometrial prostanoid profiles in three infertile subgroups:
      The missing part of receptivity? <em>Fertility and
      Sterility</em>.</div>
      </div>
      <div id="ref-18" class="csl-entry">
      <div class="csl-left-margin">14. </div><div class="csl-right-inline">Ülgen, E., Karacan, S., Gerlevik, U.,
      Can, Ö., Bilguvar, K., Oktay, Y., Akyerli, C. B., &amp; …. (2020).
      Mutations and copy number alterations in IDH wild-type
      glioblastomas are shaped by different oncogenic mechanisms.
      <em>Biomedicines</em>.</div>
      </div>
      <div id="ref-29" class="csl-entry">
      <div class="csl-left-margin">15. </div><div class="csl-right-inline">Ozduman, K., Ulgen, E., Karacan, S.,
      Gerlevik, U., Can, O., Bilguvar, K., &amp; …. (2020). Mutations
      and copy number alterations in diffuse gliomas are shaped by
      different mechanisms. <em>European Journal of Cancer</em>.</div>
      </div>
      <div id="ref-1" class="csl-entry">
      <div class="csl-left-margin">16. </div><div class="csl-right-inline">Ulgen, E., Ozisik, O., &amp; Sezerman, O.
      (2019). pathfindR: An r package for comprehensive identification
      of enriched pathways in omics data through active subnetworks.
      <em>Frontiers in Genetics</em>.</div>
      </div>
      <div id="ref-2" class="csl-entry">
      <div class="csl-left-margin">17. </div><div class="csl-right-inline">Bastu, E., Demiral, I., Gunel, T., Ulgen,
      E., Gumusoglu, E., Hosseini, M., &amp; …. (2019). Potential marker
      pathways in the endometrium that may cause recurrent implantation
      failure. <em>Reproductive Sciences</em>.</div>
      </div>
      <div id="ref-8" class="csl-entry">
      <div class="csl-left-margin">18. </div><div class="csl-right-inline">Ülgen, E., Bektaşoğlu, P., Sav, M., Can,
      Ö., Danyeli, A., Hızal, D., Pamir, M., &amp; …. (2019).
      Meningiomas display a specific immunoexpression pattern in a
      rostrocaudal gradient: An analysis of 366 patients. <em>World
      Neurosurgery</em>.</div>
      </div>
      <div id="ref-9" class="csl-entry">
      <div class="csl-left-margin">19. </div><div class="csl-right-inline">Ülgen, E., Can, Ö., Bilguvar, K., Oktay,
      Y., Akyerli, C., Danyeli, A., Yakıcıer, M., &amp; …. (2019). Whole
      exome sequencing–based analysis to identify DNA damage repair
      deficiency as a major contributor to gliomagenesis in adult
      diffuse gliomas. <em>Journal of Neurosurgery</em>.</div>
      </div>
      <div id="ref-11" class="csl-entry">
      <div class="csl-left-margin">20. </div><div class="csl-right-inline">Sezerman, O., Ulgen, E., Seymen, N.,
      &amp; Durasi, I. (2019). Bioinformatics workflows for genomic
      variant discovery, interpretation and prioritization.
      <em>Bioinformatics Tools for Detection and Clinical Interpretation
      of Genomic …</em>.</div>
      </div>
      <div id="ref-17" class="csl-entry">
      <div class="csl-left-margin">21. </div><div class="csl-right-inline">Ulgen, E., &amp; Ozisik, O. (2019).
      pathfindR: An r package for comprehensive identification of
      enriched pathways in omics data through active subnetworks. Front
      genet 10: 858 59 dogan b, gumusoglu e, ulgen e …. <em>Genomics
      Inform</em>.</div>
      </div>
      <div id="ref-4" class="csl-entry">
      <div class="csl-left-margin">22. </div><div class="csl-right-inline">Akyerli, C., Yüksel, Ş., Can, Ö.,
      Erson-Omay, E., Oktay, Y., Coşgun, E., &amp; …. (2018). Use of
      telomerase promoter mutations to mark specific molecular subsets
      with reciprocal clinical behavior in IDH mutant and IDH wild-type
      diffuse gliomas. <em>Journal of Neurosurgery</em>.</div>
      </div>
      <div id="ref-6" class="csl-entry">
      <div class="csl-left-margin">23. </div><div class="csl-right-inline">Ulgen, E., Ozisik, O., &amp; Sezerman, O.
      (2018). pathfindR: An r package for pathway enrichment analysis
      utilizing active subnetworks. <em>BioRxiv</em>.</div>
      </div>
      <div id="ref-30" class="csl-entry">
      <div class="csl-left-margin">24. </div><div class="csl-right-inline">Bastu, E., Demiral, I., Ulgen, E., Erkan,
      M., Celik, S., Aydin, Y., Onem, A., &amp; …. (2018). Lipidomic
      analysis reveals increased TXA2 presence in non-receptive
      endometrium of recurrent miscarriage and repeated implantation
      failure patients. <em>HUMAN REPRODUCTION</em>.</div>
      </div>
      <div id="ref-31" class="csl-entry">
      <div class="csl-left-margin">25. </div><div class="csl-right-inline">Dogan, M., Demiral, I., Akgun, E., Ulgen,
      E., Gurel, B., Sahin, B., Aytan, A., &amp; …. (2018). Endometrial
      proteomic signature in recurrent implantation failure. <em>HUMAN
      REPRODUCTION</em>.</div>
      </div>
      <div id="ref-32" class="csl-entry">
      <div class="csl-left-margin">26. </div><div class="csl-right-inline">Demiral, I., Gumusoglu, E., Ulgen, E.,
      Hosseini, M., Ozgor, B., Dogan, M., &amp; …. (2018). Endometrial
      transcriptomic pathways analysis in recurrent miscarriages and
      unexplained infertility. <em>HUMAN REPRODUCTION</em>.</div>
      </div>
      <div id="ref-33" class="csl-entry">
      <div class="csl-left-margin">27. </div><div class="csl-right-inline">Ozduman, K., Ulgen, E., Can, O., Akyerli,
      C., &amp; Pamir, M. (2018). Analysis of mutational processes in 23
      adult hemispheric diffuse gliomas identifies DNA-damage repair
      deficiency as a major contributor to gliomagenesis. <em>JOURNAL OF
      NEUROSURGERY</em>.</div>
      </div>
      <div id="ref-34" class="csl-entry">
      <div class="csl-left-margin">28. </div><div class="csl-right-inline">Siva, A., Everest, E., Ülgen, E.,
      UygunoÄŸlu, U., Tütüncü, M., Saip, S., &amp; …. (2018).
      Identification of multiple sclerosis related pathways through
      genome-proteome correlations. <em>ACTRIMS Forum</em>.</div>
      </div>
      <div id="ref-7" class="csl-entry">
      <div class="csl-left-margin">29. </div><div class="csl-right-inline">Çağlayan, A., Sezer, R., Kaymakçalan, H.,
      Ulgen, E., Yavuz, T., &amp; …. (2017). ALPK3 gene mutation in a
      patient with congenital cardiomyopathy and dysmorphic features.
      <em>Molecular Case Studies</em>.</div>
      </div>
      <div id="ref-22" class="csl-entry">
      <div class="csl-left-margin">30. </div><div class="csl-right-inline">Ülgen, E., &amp; Asar, Ö. (2017).
      Tekrarlı gözlem ve sağkalım verilerinin bileşik modellenmesi.
      <em>Türkiye Klinikleri Biyoistatistik</em>.</div>
      </div>
      <div id="ref-35" class="csl-entry">
      <div class="csl-left-margin">31. </div><div class="csl-right-inline">Demiral, I., Bastu, E., Gunel, T.,
      Sezerman, U., Gumusoglu, E., Ulgen, E., &amp; …. (2017).
      Endometrial gene expression in patients with recurrent
      implantation failure. <em>Fertility and Sterility</em>.</div>
      </div>
      <div id="ref-36" class="csl-entry">
      <div class="csl-left-margin">32. </div><div class="csl-right-inline">Bastu, E., Gunel, T., Sezerman, O.,
      Demiral, I., Gumusoglu, E., Ulgen, E., &amp; …. (2017). RAC1
      signaling pathway is crucial for etiology of repeated implantation
      failure (RIF). <em>Fertility and Sterility</em>.</div>
      </div>
      <div id="ref-5" class="csl-entry">
      <div class="csl-left-margin">33. </div><div class="csl-right-inline">Oktay, Y., Ülgen, E., Can, Ö., Akyerli,
      C., Yüksel, Ş., Erdemgil, Y., Durası, İ., &amp; …. (2016).
      IDH-mutant glioma specific association of rs55705857 located at
      8q24. 21 involves MYC deregulation. <em>Scientific
      Reports</em>.</div>
      </div>
      <div id="ref-15" class="csl-entry">
      <div class="csl-left-margin">34. </div><div class="csl-right-inline">Per, H., Canpolat, M., Bayram, A., Ulgen,
      E., Baran, B., Kardas, F., Gumus, H., &amp; …. (2015). Clinical,
      electrodiagnostic, and genetic features of tangier disease in an
      adolescent girl with presentation of peripheral neuropathy.
      <em>Neuropediatrics</em>.</div>
      </div>
      <div id="ref-16" class="csl-entry">
      <div class="csl-left-margin">35. </div><div class="csl-right-inline">Bayram, A., Per, H., Quon, J., Canpolat,
      M., Ülgen, E., Doğan, H., Gumus, H., &amp; …. (2015). A rare case
      of congenital fibrosis of extraocular muscle type 1A due to KIF21A
      mutation with marcus gunn jaw-winking phenomenon. <em>European
      Journal of Paediatric Neurology</em>.</div>
      </div>
      </div>
      </div>
    </div>
  </div>
</body>
</html>
